NewAmsterdam Pharma NAMS Balance Sheet (2021-2026)

NASDAQ NAMS
$23.81 +0.23 (+0.98%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

NewAmsterdam Pharma Quarterly Balance Sheet

Periods 16 quarters
Latest Jun 2026

NewAmsterdam Pharma reported total assets of $704.45M and total liabilities of $73.03M for the quarter ended Jun 2026, down 13.6% year over year. This balance sheet covers 16 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2021 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 60.74M447.40M441.31M416.71M368.31M340.45M481.15M430.71M422.73M771.74M748.42M563.86M538.41M490.00M457.61M424.15M
Receivables - OtherOther Receivables 0.88M3.98M2.13M1.65M1.75M1.44M3.29M3.90M6.76M8.02M5.11M
Prepaid Assets 6.61M9.81M6.28M6.34M6.67M14.64M15.14M24.27M8.83M30.69M28.07M38.14M20.60M24.00M
Current Assets 67.35M457.21M423.88M346.79M487.82M445.35M437.87M863.41M817.30M769.85M732.33M675.70M658.04M659.21M
Non-Current Assets
Property, Plant & Equipment (Net) 0.22M0.15M0.12M0.05M0.10M0.23M0.23M0.24M0.24M0.31M0.32M0.38M0.38M0.41M
Long-Term Investments 44.17M53.09M92.61M71.24M44.41M
Intangibles 84.84M88.89M
Goodwill & Intangibles 84.84M88.89M0.17M0.49M0.54M0.59M0.53M0.50M0.47M0.44M0.41M0.38M0.34M
Other Non-Current Assets 0.15M0.10M0.04M0.02M0.01M2.58M
Non-Current Assets 1.04M85.14M89.11M0.31M0.64M1.34M1.32M1.21M1.11M45.26M54.10M93.58M74.60M45.24M
Assets 68.39M542.35M512.99M347.10M488.46M446.69M439.19M864.62M818.41M815.11M786.43M769.28M732.64M704.45M
Liabilities
Current Liabilities
Accounts Payables 11.24M18.88M22.71M16.92M9.97M10.19M10.58M13.61M8.02M9.46M10.10M15.42M8.09M10.28M
Payables 11.24M18.88M22.71M16.92M9.97M10.19M10.58M13.61M8.02M9.46M10.10M15.42M8.09M10.28M
Current Leases 0.06M0.06M0.07M
Current Deferred Revenue 4.58M3.18M8.94M8.12M6.06M4.50M6.01M3.03M3.99M3.99M2.80M
Total Current Liabilities 11.30M36.18M41.74M49.90M59.73M45.31M41.26M106.92M40.91M36.51M58.27M85.79M67.42M72.97M
Non-Current Liabilities
Non-Current Deffered Revenue 4.79M1.02M0.44M0.22M
Operating Leases 0.13M0.06M0.03M0.33M0.27M0.20M0.14M0.10M0.09M0.07M0.06M
Other Non-Current Liabilities 7.20M8.22M7.79M16.49M13.39M18.81M
Total Non-Current Liabilities 0.13M11.84M11.43M50.92M60.17M45.86M41.52M
Total Liabilities 11.43M48.01M53.18M58.70M76.66M59.25M60.33M107.12M41.05M36.62M58.36M85.85M67.42M73.03M
Shareholder's Equity
Common Equity 56.96M494.33M398.41M373.34M331.83M288.39M411.80M387.44M378.86M757.50M777.36M778.50M728.07M683.43M665.22M631.42M
Liabilities and Shareholders Equity 68.39M542.35M512.99M347.10M488.46M446.69M439.19M864.62M818.41M815.11M786.43M769.28M732.64M704.45M
Retained Earnings -39.67M-121.78M-211.76M-316.97M-410.74M-449.75M-466.39M-558.57M-598.10M-615.46M-687.47M-762.39M-810.83M-874.97M

NewAmsterdam Pharma Balance Sheet API

Pull NewAmsterdam Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NAMS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY